17-1.
(Developmental) Increase the proportion of health organizations that are linked in an integrated system that monitors and reports adverse events.
| | |
17-1. | |
(Developmental) Increase the proportion of health organizations that are linked in an integrated system that monitors and reports adverse events. |
17-1a. Health care organizations that are linked in an integrated system that monitors and reports adverse events associated with medical therapies.
17-1b. Health care organizations that are linked in an integrated system that monitors and reports adverse events associated with medical devices.
Potential data sources: Office of Postmarketing Drug Risk Assessment (OPDRA), MedWatch, and Manufacturer and User Device Experience (MAUDE) Database, FDA.